AGAbdelrahman G. Gadallah

Abdelrahman G. Gadallah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abdelrahman G. Gadallah has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pluronic F127 –Folic Acid Modified Nickel Oxide Nanocomposites via a Facile One‐Pot Approach for In Vitro Anticancer, Antibacterial, and DPPH Radical Scavenging Studies

    by Abdelrahman G. Gadallah, Indumathi Thangavelu, Srinivas Tadepalli, Palanisamy Arulselvan

    Drug‐resistant bacteria and cancer remain major challenges in healthcare, highlighting the need for multifunctional nanomaterials. In this study, folic acid‐ and Pluronic F127‐modified nickel oxide nanocomposites (NiO–PF127–FA) were synthesized via a one‐pot method, and their in vitro antibacterial, antioxidant, and anticancer properties were evaluated. XRD analysis showed a crystallite size of 19.42 nm for NiO–PF127–FA, while PL spectra exhibited a green emission peak at 507 nm, indicative of structural defects in the NiO lattice. NiO–PF127–FA displayed enhanced antibacterial activity against MRSA and Candida albicans compared to bare NiO, as evidenced by larger inhibition zones and lower MIC and MBC values. The DPPH assay demonstrated improved radical scavenging activity of the modified nanocomposites, likely related to their smaller size, higher surface area, and surface defect‐mediated electron transfer. In vitro anticancer studies using rat C6 glioblastoma cells revealed dose‐dependent decreases in cell viability, with IC50 values of 12.3 μg/mL for NiO and 9.6 μg/mL for NiO–PF127–FA. Fluorescence staining with AO/EB and DAPI indicated morphological changes in nuclei and alterations in MMP, consistent with induction of cell death. Overall, these findings suggest that NiO–PF127–FA nanocomposites exhibit improved in vitro biological activity, providing a foundation for further preclinical investigations of their potential biomedical applications.


  • Biogenic Carboxymethyl Cellulose and L‐Histidine Coated Barium Peroxide Nanocomposite: A Tri‐Functional Platform Targeting Antimicrobial Resistance, Cancer, and Oxidative Stress

    by Srinivas Tadepalli, Mahendra Singh Rathore, Suhas Ballal, Indumathi Thangavelu, Abdelrahman G. Gadallah

    The study addresses the urgent need for novel therapeutic agents in combating multidrug‐resistant pathogens, cancer, and oxidative stress‐related diseases. Barium peroxide (BaO 2 ) nanoparticles and its novel nanocomposite, carboxymethyl cellulose and L‐histidine coated BaO 2 (BaO 2 ‐CMC‐LH) were synthesized, characterized, and evaluated for their antibacterial, anticancer, and DPPH radical scavenging activities. Structural and functional characterizations were carried out using various analytical techniques. Biological evaluations demonstrated enhanced antibacterial activity against Methicillin‐resistant Staphylococcus aureus (MRSA) and Candida albicans ( C. albicans ), with BaO 2 ‐CMC‐LH exhibiting superior inhibition zones compared to BaO 2 . For MRSA, the zone of inhibition (ZOI) for BaO 2 is about 9 mm, whereas the BaO 2 ‐CMC‐LH nanocomposite exhibits a substantially larger ZOI of 21 mm. Likewise, for C. albicans , BaO 2 presents a ZOI of 12 mm, and BaO 2 ‐CMC‐LH exhibits a greater inhibition zone of 18 mm. Cytotoxicity analysis against osteosarcoma MG‐63 cells revealed significantly improved anticancer activity, with BaO 2 ‐CMC‐LH achieving an IC₅₀ value of 28.6 μg/mL compared to 53.3 μg/mL for BaO 2 . The 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) free radical scavenging assay showed that the BaO 2 ‐CMC‐LH nanocomposite (78.45%) had activity compared to BaO 2 alone (64.43%). These findings underscore the synergistic effects of the CMC‐LH matrix in enhancing BaO 2 's biological activities, positioning BaO 2 ‐CMC‐LH as a promising multifunctional therapeutic agent for addressing global health challenges.